These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2443088)

  • 21. Cooperation between fibronectin and heparin in the mobilization of capillary endothelium.
    Ungari S; Katari RS; Alessandri G; Gullino PM
    Invasion Metastasis; 1985; 5(4):193-205. PubMed ID: 2409044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations on the mechanism of the angiogenic response.
    Gullino PM
    Anticancer Res; 1986; 6(2):153-8. PubMed ID: 2423012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses.
    Sakamoto N; Tanaka NG; Tohgo A; Osada Y; Ogawa H
    J Natl Cancer Inst; 1987 Mar; 78(3):581-5. PubMed ID: 2434705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis and heparin mimics.
    Weisz PB; Hermann HC; Joullié MM; Kumor K; Levine EM; Macarak EJ; Weiner DB
    EXS; 1992; 61():107-17. PubMed ID: 1377523
    [No Abstract]   [Full Text] [Related]  

  • 25. Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
    Pisano C; Aulicino C; Vesci L; Casu B; Naggi A; Torri G; Ribatti D; Belleri M; Rusnati M; Presta M
    Glycobiology; 2005 Feb; 15(2):1C-6C. PubMed ID: 15496501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
    Maragoudakis ME; Sarmonika M; Panoutsacopoulou M
    J Pharmacol Exp Ther; 1989 Nov; 251(2):679-82. PubMed ID: 2478695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of angiogenesis.
    Folkman J; Ingber D
    Semin Cancer Biol; 1992 Apr; 3(2):89-96. PubMed ID: 1378314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation.
    Colville-Nash PR; Alam CA; Appleton I; Brown JR; Seed MP; Willoughby DA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1463-72. PubMed ID: 7562523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.
    Wilks JW; Scott PS; Vrba LK; Cocuzza JM
    Int J Radiat Biol; 1991; 60(1-2):73-7. PubMed ID: 1713944
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.
    Pepper MS; Vassalli JD; Wilks JW; Schweigerer L; Orci L; Montesano R
    J Cell Biochem; 1994 Aug; 55(4):419-34. PubMed ID: 7525617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of angiogenesis: a new function of heparin.
    Folkman J
    Biochem Pharmacol; 1985 Apr; 34(7):905-9. PubMed ID: 2580535
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of angiostatic steroids to inhibit cartilage destruction in an in vivo model of granuloma-mediated cartilage degradation.
    Colville-Nash PR; el-Ghazaly M; Willoughby DA
    Agents Actions; 1993 Jan; 38(1-2):126-34. PubMed ID: 8480533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiogenesis by antiestrogens.
    Gagliardi A; Collins DC
    Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW; Casey R; Gonzalez EM; Folkman J
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour angiogenesis.
    Schor AM; Schor SL
    J Pathol; 1983 Nov; 141(3):385-413. PubMed ID: 6198502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of heparin in neoplastic angiogenesis].
    Sikora J; Radomyski A
    Pneumonol Alergol Pol; 1995; 63(5-6):344-8. PubMed ID: 7581072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
    Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
    Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis.
    Ondrick K; Samojla BG
    Clin Podiatr Med Surg; 1992 Jan; 9(1):185-202. PubMed ID: 1370913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis inhibition by minocycline.
    Tamargo RJ; Bok RA; Brem H
    Cancer Res; 1991 Jan; 51(2):672-5. PubMed ID: 1702361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.